| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/03/2007 | EP1737452A1 Angiogenesis-affecting compounds and methods of use thereof |
| 01/03/2007 | EP1737379A2 Bioactive stents for type ii diabetics and methods for use thereof |
| 01/03/2007 | EP1476467B9 Immunoglobulin igg3 as a marker for protecting against infectious viral diseases, and the uses of the same |
| 01/03/2007 | EP1448771B1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof |
| 01/03/2007 | EP1432442B1 The use of liposomes containing saponins and sterols in the manufacture of intradermal vaccines |
| 01/03/2007 | EP1401872B1 Antigen targeting |
| 01/03/2007 | EP1390403B1 Peptides derived from neural thread proteins and their medical use |
| 01/03/2007 | EP1385876B1 Gonococcal proteins and nucleic acids |
| 01/03/2007 | EP1383514B1 Use of a composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
| 01/03/2007 | EP1326636B1 Vaccine composition |
| 01/03/2007 | EP1322292B1 Microparticle compositions and methods for the manufacture thereof |
| 01/03/2007 | EP1278534B1 Methods and compositions for impairing multiplication of hiv-1 |
| 01/03/2007 | EP1267920B1 Compositions comprising cold-adapted equine influenza viruses for the treatment of existing viral infections of the respiratory system. |
| 01/03/2007 | EP1173765B1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/03/2007 | EP1108435B1 Preventives or remedies for pancreatitis containing anti-il-6 receptor antibodies as the active ingredient |
| 01/03/2007 | EP1104462B1 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 01/03/2007 | EP1044014B9 Agent for treating allergic or hypersensitivity condition |
| 01/03/2007 | EP0929315B1 Cross-protective equine herpesvirus preparations and method of making and using the same |
| 01/03/2007 | EP0904090B1 Egg anti-inflammatory composition, method of isolation and use |
| 01/03/2007 | EP0896626B1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system |
| 01/03/2007 | EP0787139B1 Synthetic peptides and vaccines comprising same |
| 01/03/2007 | EP0776361B1 Recombinant herpesvirus of turkeys and uses thereof |
| 01/03/2007 | EP0771213B1 Haemophilus influenzae adherence and penetration proteins |
| 01/03/2007 | EP0726952B1 Receptor on the surface of activated t-cells:acts-4 |
| 01/03/2007 | EP0526452B2 Hybrid immunoglobulins |
| 01/03/2007 | CN1890567A Angiogenesis inhibiting molecules and their use in the treatment and diagnosis of cancer |
| 01/03/2007 | CN1890383A Hinge core mimetibodies, compositions, methods and uses |
| 01/03/2007 | CN1890374A Chimeric carrier molecules for the production of mucosal vaccines |
| 01/03/2007 | CN1890369A Bispecific antibody substituting for functional proteins |
| 01/03/2007 | CN1890266A Antibodies |
| 01/03/2007 | CN1890261A Protein NMB0928 and use thereof in pharmaceutical formulations |
| 01/03/2007 | CN1890260A Protein NMB1125 and use thereof in pharmaceutical formulations |
| 01/03/2007 | CN1890252A New class of gamma delta T cells activators and use thereof |
| 01/03/2007 | CN1889979A IP-10 antibodies and their uses |
| 01/03/2007 | CN1889978A Interferon alpha antibodies and their uses |
| 01/03/2007 | CN1889977A Vaccine compositions comprising an interleukin 18 and saponin adjuvant system |
| 01/03/2007 | CN1889976A Pharmaceutical anti-herpetic composition, method for producing a dosage form based thereon and method for the use thereof |
| 01/03/2007 | CN1889975A Liquid vaccines for multiple meningococcal serogroups |
| 01/03/2007 | CN1889963A 方法 Method |
| 01/03/2007 | CN1887907A Recombinant Plasmodium falciparum 175kD erythrocyte conjugated antigen functional region protein and its prepn and use |
| 01/03/2007 | CN1887901A Human tumor M2-type pyruvate kinase antigen determinant polypeptide and antibody and their application in diagnositic kit |
| 01/03/2007 | CN1887351A Hepatitis B preventing vaccine and its prepn |
| 01/03/2007 | CN1887350A Recombinant vaccine and its use |
| 01/03/2007 | CN1887349A Helicobacter pylori vaccine based on urease B subunit active segment and its prepn process |
| 01/03/2007 | CN1887348A Inactivated chicken shigalla vaccine and its prepn |
| 01/03/2007 | CN1887275A Prepn process of polysaccharide vitreous particle carrying active vaccine or antibody |
| 01/03/2007 | CN1293195C Reverse genetic operation system of New castle disease LaSota vaccine strain and its applciation |
| 01/03/2007 | CN1293192C Immunoregulation polynucleotide and using method thereof |
| 01/03/2007 | CN1293190C Cell surface molecule mediating cell adhesion and signal transmission |
| 01/03/2007 | CN1292795C Vaccine against salmonid rickettsial septicaemia based on arthrobacter cells |
| 01/03/2007 | CN1292794C Preparation of immuno-stimulation composition for hemolycin in monad |
| 01/03/2007 | CN1292669C Cow colostrum active immunological globulin thermal denaturation preserving agent |
| 01/03/2007 | CN1292655C Stable liquid pharmaceutical formulation of IgG antibodies |
| 01/02/2007 | US7157570 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosis, prognosis and treatment of cell proliferative disorders |
| 01/02/2007 | US7157569 Comprises nucleotide sequences coding gamma aminobutyric acid type A (GABAA) receptor for diagnosis and treatment of brain, anxiety, depressive, nervous system, migraine and/or obesity disorders |
| 01/02/2007 | US7157559 Homogeneous preparations of IL-28 and IL-29 |
| 01/02/2007 | US7157500 Nitrosylation of protein SH groups and amino acid residues as a therapeutic modality |
| 01/02/2007 | US7157458 Bifunctional energy-reversible acyl-compositions |
| 01/02/2007 | US7157443 High molecular weight intracellular adhesin antigen; induction immunology response |
| 01/02/2007 | US7157439 a cellulose and a HoxB3 homeotic nucleic acid or protein; improved neovascularization |
| 01/02/2007 | US7157437 Administering polynucleotide comprising an immunostimulatory sequence (ISS) to an individual exposed to herpes simplex virus, wherein the ISS comprises the sequence 5'-C, G-3', wherein the polynucleotide comprises a phosphate backbone modification, wherein the polynucleotide is greater than 6 nucleotides |
| 01/02/2007 | US7157245 Neisserial vaccine compositions and methods |
| 01/02/2007 | US7157240 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 01/02/2007 | US7157238 Identifying micrometastsized tissue/masses using double immunoglobulin labeling; immunodiagnostics and cancer detection |
| 01/02/2007 | US7157226 probes, vectors and kits; sequences from the Core/E1 region of HCV type 3; detection of HCV infection |
| 01/02/2007 | US7157225 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens |
| 01/02/2007 | US7157089 A fusion protein containing an antigen of an influenza virus and a bacterial stress protein; vaccines induce a cytolytic T-cell (CTL) response in a mammal |
| 01/02/2007 | US7157088 Surface protein of Leptospira |
| 01/02/2007 | US7157087 Modifying selected antibodies with biotin and streptavidin, conjugating these antibodies with an effector molecule, and delivering the conjugated effector to an intracellular target |
| 01/02/2007 | US7157086 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation. |
| 01/02/2007 | US7157085 Method for treating IgE-mediated disorders |
| 01/02/2007 | US7157084 Extracellular serine protease |
| 01/02/2007 | US7157083 Aid therapy |
| 01/02/2007 | US7157081 Uses of aldose-1-epimerase (mutarotase) for diagnosis and therapy of inflammatory diseases and sepsis |
| 01/02/2007 | CA2311336C Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same |
| 01/02/2007 | CA2237059C Targeted adenovirus vectors |
| 12/28/2006 | WO2006138745A2 Therapeutic peptides and vaccines |
| 12/28/2006 | WO2006138708A1 Lkktet and/or lkktnt peptide compositions which are lyophilized or in a form capable of being lyophilized |
| 12/28/2006 | WO2006138707A1 Lkktet and/or lkktnt compositions and methods for treating or preventing tissue deterioration, injury or damage |
| 12/28/2006 | WO2006138690A2 Improved method of treating degenerative spinal disorders |
| 12/28/2006 | WO2006138681A2 Methods and compositions for enhancing immune memory by blocking intrahepatic activated t cell deletion |
| 12/28/2006 | WO2006138670A2 Antibody complexes |
| 12/28/2006 | WO2006138627A2 Monoclonal antibodies recognizing a coagulase-negative staphylococcal protein |
| 12/28/2006 | WO2006138568A2 Multivalent entrain-and-amplify immunotherapeutics for carcinoma |
| 12/28/2006 | WO2006138567A2 Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma |
| 12/28/2006 | WO2006138514A2 Novel norovirus particle for use as an antiviral or vaccine |
| 12/28/2006 | WO2006138509A2 Immunoreactive protein orthologs of ehrlichia canis and e. chaffeensis |
| 12/28/2006 | WO2006138478A2 Stimulation of toll-like receptors on t cells |
| 12/28/2006 | WO2006138435A2 Methods for enhancing immune responses |
| 12/28/2006 | WO2006138324A2 Treponema pallidum antigens for vaccine development and diagnostic tests |
| 12/28/2006 | WO2006138248A2 Vaccines for protection from bartonella infection and related methods |
| 12/28/2006 | WO2006138181A2 Self-buffering protein formulations |
| 12/28/2006 | WO2006138127A2 Botulinum toxin and the treatment of primary disorders of mood and affect |
| 12/28/2006 | WO2006137938A2 Antibody fragments for protection from pathogen infection and methods of use thereof |
| 12/28/2006 | WO2006137934A2 Purposeful movement of human migratory cells away from an agent source |
| 12/28/2006 | WO2006137838A2 Methods and compositions for diagnosing and preventing a group b streptococcal infection |
| 12/28/2006 | WO2006137597A1 Novel physiological substance nesfatin, substance relevant thereto, and use of the substances |
| 12/28/2006 | WO2006137595A1 Prophylactic/therapeutic agent for her2-expressing cancer |
| 12/28/2006 | WO2006137514A1 Therapeutic agent for cancer comprising substance capable of inhibiting expression or function of synoviolin as active ingredient and screening method for the therapeutic agent for cancer |
| 12/28/2006 | WO2006137354A1 Antibody having inhibitory effect on amyloid fibril formation |